Stroke and the Blood-Brain Interface

Blood-Brain Barriers: From Ontogeny to Artificial Interfaces

Volumn 1, Issue , 2007, Pages 619-647

  Cipolla, Marilyn J ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

Astrocytes; Blood brain interface; Brain edema formation; Cellular regulation; Cerebrovascular permeability; Disease related response; Hemodynamic changes; Hyperglycemic stroke; Ischemia; Mediating edema; Mediators of EC permeability; Reperfusion injury; Stroke; Transcellular transport

Indexed keywords

BRAIN INTERFACES;

EID: 84890989104     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527611225.ch25     Document Type: Chapter

References (190)

1. Williams GR, Jiang J, Matchar DB, Samsa GP 1999, Incidence and occurrence of total (first-ever and recurrent) stroke, Stroke 30, 2523-2529.
2. Hacke W, Steiner T, Schwab S 1997, Critical management of acute stroke:medical and surgical therapy, in Cerebrovascular Disease, ed. HH Batjer, Lippincott-Raven, Philadelphia.
3. Dirnagl U, Lindauer U 1998, Microcirculatory disturbances in cerebral ischemia, in Cerebrovascular Disease: Pathophysiology, Diagnosis and Management, vol. 1, eds. MD Ginsberg, J Bogousslavsky, Blackwell Science, Malden.
4. Kniesel U, Wolburg H 2000, Tight junctions of the blood-brain barrier, Cell Mol Neurobiol 20, 57-76.
5. Rubin LL, Standdon JM 1999, The cell biology of the blood-brain barrier, Annu Rev Neurosci 22, 11-28.
6. Betz AL, Dietrich WD 1998, Blood-brain barrier dysfunction in cerebral ischemia, in Cerebrovascular Disease: Pathophysiology, Diagnosis and Management, vol. 1, eds. MD Ginsberg, J Bogousslavsky, Blackwell Science, Malden.
7. Wahl M, Unterberg A, Baethmann A, Schilling L 1988, Mediators of bloodbrain barrier dysfunction and formation of vasogenic brain edema, J Cereb Blood Flow Metab 8, 621-634.
8. Johansson B 1974, Blood-brain barrier dysfunction in acute arterial hypertension after papaverine-induced vasodilatation, Acta Neurol Scand 50, 573-580.
9. Cipolla MJ, Crete R, Vitullo L, Rix RD 2004, Transcellular transport as a mechanism of blood-brain barrier disruption during stroke, Front Biosci 9, 777-785.
10. Krizanac-Bengez L, Kapural M, Parkinson F, Cucullo L, Hossain M, Mayberg M, Janigro D 2003, Effects of transient loss of shear stress on blood-brain barrier endothelium: role of nitric oxide and IL-6, Brain Res 977, 239-246.
11. Mark KS, Burroughs AR, Brown RC, Huber JD, Davis TP 2003, Nitric oxide mediates hypoxia-induced changes in paracellular permeability of cerebral microvasculature, Am J Physiol 286, H174-H180.
12. Ramirez MM, Kim DD, Duran WN 1996, Protein kinase C modulates microvascular permeability through nitric oxide synthase, Am J Physiol 271, H1702-H1705.
13. Plateel M, Dehouck P, Torpier G, Cecchelli R, Teissier E 1995, Hypoxia increases the susceptibility to oxidant stress and the permeability of the bloodbrain barrier endothelial cell monolayer, J Neurochem 65, 2138-2145.
14. Blum MS, Toninelli E, Anderson JM, Balda MS, Zhou J, O'Donnel L, Pardi R, Bender JR 1997, Cytoskeletal rearrangement mediates human microvascular endothelial tight junction modulation by cytokines, Am J Physiol 273, H286-H294.
15. Goeckeler ZM, Wysolmerski RB 1995, Myosin light chain kinase-regulated endothelial cell contraction: relationship between isometric tension, actin polymerization and myosin phosphorylation, J Cell Biol 130, 613-627.
16. Nag S 1995, Role of endothelial cytoskeleton in blood-brain barrier permeability to protein, Acta Neuropathol 90, 454-460.
17. Ropper AH, Shafran B 1984, Brain edema after stroke: clinical syndrome and intracranial pressure, Arch Neurol 41, 26-29.
18. Oxbury JM, Greenhall RC, Grainger KM 1975, Predicting outcome of stroke:acute stage after cerebral infarction, Br Med J 3, 125-127.
19. Bounds JV, Wiebers DO, Whisnant JP, Okazaki H 1981, Mechanisms and timing of deaths from cerebral infarction, Stroke 12, 474-477.
20. Iannotti F, Hoff JT, Schielke GP 1985, Brain tissue pressure in focal cerebral ischemia, J Neurosurg 62, 83-89.
21. Koudstaal PJ, Stibbe J, Vermeulen M 1988, Fatal ischaemic brain oedema after early thrombolysis with tissue plasminogen activator, Br Med J 297, 1571-1574.
22. Bell BA, Symon TD, Branston NM 1985, CBF and time thresholds for the formation of ischemic cerebral edema and effect of perfusion in the baboon, J Neurosurg 62, 31-41.
23. Brott TG, Hacke W 1998, Thrombolytic and defibrinogenating agents for ischemic and hemorrhagic stroke, in Stroke: Pathophysiology, Diagnosis and Management, ed. Barnett E, Churchill Livingstone, Philadelphia, pp. 1164-1165.
24. Klatzo I 1967, Neuropathologic aspects of brain edema, J Neuropathol Exp Neurol 26, 1-14.
25. Yang GY, Chen SF, Kinouchi H, et al. 1992, Edema, cation content, and ATPase activity after middle cerebral artery occlusion in rats, Stroke 23, 1331-1336.
26. Betz AL, Keep RF, Beer ME, Ren X-D 1994, Blood-brain barrier permeability and brain content of sodium, potassium and chloride during focal ischemia, J Cereb Blood Flow Metab 14, 29-37.
27. Young W, Rappaport ZH, Chalif DJ, Flamm ES 1987, Regional brain sodium, potassium, and water changes in the rat middle cerebral artery occlusion model of ischemia, Stroke 18, 751-759.
28. Betz AL, Ennis SR, Schielke GP 1989, Blood-brain barrier sodium transport limits development of brain edema during partial ischemia in gerbils, Stroke 20, 1253-1259.
29. 125I-albumin, Stroke 16, 101-109.
30. Dietrich WD, Prado R, Watson BD, Nakayama H 1988, Middle cerebral artery thrombosis: acute blood-brain barrier alterations, J Neuropath Exp Neurol 47, 443-451.
31. Hassel B, Iversen EG, Fonnum F 1986, Neurotoxicity of albumin in vivo, Neurol Res 8, 146-151.
32. Fenstermacher JD 1984, Volume regulation of the central nervous system, in Edema, eds. NC Staub, AE Taylor, Raven Press, New York, pp. 383-404.
33. Dodson RF, Chu LW, Welch KM, Achar VS 1977, Acute tissue response to cerebral ischemia in the gerbil: an ultrastructural study, J Neurol Sci 33, 161-170.
34. Chen Y, Swanson RA 2003, Astrocytes and brain injury, J Cereb Blood Flow Metab 23, 137-149.
35. Anderson CM, Swanson RA 2000, Astrocyte glutamate transport: review of properties, regulation and physiological functions, Glia 32, 1-14.
36. Walz W, Hertz L 1983, Functional interactions between neurons and astrocytes, part II: potassium homeostasis at the cellular level, Prog Neurobiol 20, 133-183.
37. Tanaka J, Toku K, Zhang B, Ishihara K, Sakanaka M, Maeda N 1999, Astrocytes prevent neuronal death induced by reactive oxygen and nitrogen species, Glia 28, 85-96.
38. Reese TS, Karnovsky MJ 1976, Fine structural localization of a blood-brain barrier to exogenous peroxidase, J Cell Biol 34, 207-217.
39. Brightman MW, Reese TS 1969, Junctions between intimately apposed cell membranes in the vertebrate brain, J Cell Biol 40, 648-677.
40. Davson H, Oldendorf WH 1967, Transport in the central nervous system, Proc R Soc Med 60, 326-328.
41. Reinhart CA, Gloor SM 1997, Co-culture blood-brain barrier models and their use for pharmatoxicologic screening, Toxicol Vitro 11, 513-518.
42. Bauer HC, Bauer H 2000, Neural induction of the blood-brain barrier: still an enigma, Cell Mol Neurobiol 20, 13-28.
43. Quick AM, Cipolla MJ 2005, Pregnancy-induced upregulation of aquaporin 4 in brain and its role in eclampsia, FASEB J 19, 170-175.
44. Rash JE, Yasumura T, Hudson CS, Agre P, Neilsen S 1998, Direct immunogold labeling of aquaporin-4 in square arrays of astrocyte and ependymocyte plasma membrane in rat brain and spinal cord, Proc Natl Acad Sci USA 95, 11981-11986.
45. Butt AM, Jones HC 1992, Effect of histamine and antagonists on electrical resistance across the blood-brain barrier in rat brain-surface microvessels, Brain Res 569, 100-105.
46. Abbott NJ 2002, Astrocyte-endothelial interactions and blood-brain barrier permeability, J Anat 200, 629-638.
47. Fischer S, Wobben M, Kleinstuck J, Renz D, Schaper W 2000, Effect of astroglial cells on hypoxia-induced permeability in PBMEC cells, Am J Physiol 279, C935-C944.
48. Kondo T, Kinouchi H, Kawase M, Yoshimoto T 1996, Astroglial cells inhibit the increasing permeability of brain endothelial cell monolayer following hypoxia/reoxygenation, Neurosci Lett 208, 101-104.
49. Fischer S, Wobben M, Marti HH, Renz D, Schaper W 2002, Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGFmediated changes in the expression of zona occludens-1, Microvasc Res 63, 70-80.
50. Badaut J, Lasbennes F, Magistretti PJ, Regli L 2002, Aquaporins in the brain:distribution, physiology, and pathophysiology, J Cereb Blood Flow Metab 22, 367-378.
51. Ke C, Poon WS, NG HK, Pang JC, Chan Y 2001, Heterogeneous responses of aquaporin-4 in oedema formation in replicated severe traumatic brain injury model in rats, Neurosci Lett 301, 21-24.
52. Ishibashi K, Kuwahara M, Sasaki S 2000, Molecular biology of aquaporins, Rev Physiol Biochem Pharmacol 141, 1-32.
53. Agre P, Bonhivers M, Borgnia MJ 1998, The aquaporins, blueprints for cellular plumbing systems, J Biol Chem 273, 14659-14662.
54. Verkman AS 2002, Aquaporin water channels and endothelial cell function, J Anat 200, 617-627.
55. Amiry-Moghaddam M, Ottersen OP 2003, The molecular basis of water transport in the brain, Nat Rev Neurosci 4, 991-1001.
56. Hasegawa H, Ma T, Skach W, Matthay MA, Verkman AS 1994, Molecular cloning of a mercurial-insensitive water channel expressed in selected watertransporting tissues, J Biol Chem 269, 5497-5500.
57. Jung JS, Bhat RV, Preston GM, Guggino WB, Baraban JM, Agre P 1994, Molecular characterization of an aquaporin cDNA from brain: candidate osmoreceptor and regulator of water balance, Proc Natl Acad Sci USA 91, 13052-13056.
58. Nielsen S, Nagelhus EA, Amiry-Moghaddam M, Bourque C, Agre P, Ottersen OP 1997, Specialized membrane domains for water transport in glial cells:high-resolution immunogold cytochemistry of aquaporin-4 in rat brain, J Neurosci 17, 171-180.
59. Amiry-Moghaddam M, Xue R, Haug F-M, Neely JD, Bhardwaj A, Agre P, Adams ME, Froehner SC, Mori S, Ottersen OP 2004, Alpha syntrophin deletion removes the perivascular but not the endothelial pool of aquaporin-4 at the blood-brain barrier and delays the development of brain edema in an experimental model of acute hyponatremia, FASEB J 18, 542-544.
60. Amiry-Moghaddam M, Otuska T, Hurn PD, Traystman RJ, Haug F-M, Froehner SC, Adams ME, Neely JD, Agre P, Ottersen OP, Bhardwaj A 2003, An alpha-syntrophin-dependent pool of AQP4 in astroglial end-feet confers bidirectional water flow between blood and brain, Proc Natl Acad Sci USA 100, 2106-2111.
61. Saadoun S, Papadopoulos MC, Davies DC, Krishna S, Bell BA 2002, Aquaporin-4 expression is increased in oedematous human brain tumors, J Neurol Neurosurg Psychiat 72, 262-265.
62. Taniguchi M, Yamashita T, Kumura E, Tamatani M, Kobayashi A, Yokawa T, Maruno M, Kato A, Ohnishi T, Kohmura E, Tohyama M, Yoshimine T 2000, Induction of aquaporin-4 water channel mRNA after focal cerebral ischemia in rat, Mol Brain Res 78, 131-137.
63. Manley GT, Fujimura M, Ma T, Noshita N, Filiz F, Bollen AW, Chan P, Verkman AS 2000, Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke, Nat Med 6, 159-163.
64. Vizuete ML, Venero JL, Vargas C, Ilundain AA, Echevarria M, Machado A, Cano J 1999, Differential upregulation of aquaporin-4 mRNA expression in reactive astrocytes after brain injury: potential role in brain edema, Neurobiol Dis 6, 245-258.
65. Pardridge WM 1997, Blood-brain barrier transport mechanisms, in Primer on Cerebrovascular Disease, eds. KMA Welch, LR Caplan, RJ Reis, BK Siesjo, B Weir, Academic Press, New York, pp. 17-20.
66. Nielsen S, Smith BL, Christensen EI, Agre P 1993, Distribution of the aquaporin CHIP in secretory and resorptive epithelia and capillary endothelia, Proc Natl Acad Sci USA 90, 7275-7279.
67. Stevenson BR, Keon BH 1998, The tight junction: morphology and molecules, Annu Rev Cell Biol 14, 89-109.
68. Staddon J, Ratcliffe M, Morgan L, Hirase T, Smales C, Rubin L 1997, Protein phosphorylation and the regulation of cell-cell junctions in brain endothelial cells, Heart Vessels Suppl 12, 106-109.
69. Ito M, et al. 1999, Direct binding of three tight junction-associated MAGUKs ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins, J Cell Biol 147, 1351-1363.
70. Lum H, Malik AB 1994, Regulation of vascular endothelial barrier function, Am J Physiol 267, L223-L241.
71. Yuan Y, Huang Q, Wu HM 1997, Myosin light chain phosphorylation: modulation of basal and agonist-stimulated venular permeability, Am J Physiol 272, H1437-H1443.
72. Yuan SY 2000, Signal transduction pathways in enhanced microvascular permeability, Microcirculation 7, 395-405.
73. Garcia JG, Davis HW, Patterson CE 1995, Regulation of endothelial cell gap formation and barrier dysfunction: role of myosin light chain phosphorylation, J Cell Physiol 163, 510-522.
74. Crawford LE, Milliken EE, Iran K, Zweier JL, Becker LC, Johnson TM, Eissa NT, Crystal RG, Finkel T, Goldschmidt-Clermont PJ 1996, Superoxide-mediated actin response in post-hypoxic endothelial cells, J Biol Chem 271, 26863-26867.
75. Hippenstiel S, Tannert-Otto S, Vollrath N, Krull M, Just I, Aktories K, von Eichel-Streiber C, Suttorp N 1997, Glucosylation of small GTP-binding Rho proteins disrupts endothelial barrier function, Am J Physiol 272, L38-L43.
76. Stevenson BR, Begg DA 1994, Concentration-dependent effects of cytochalasin D on tight junctions and actin filaments in MDCK epithelial cells, J Cell Sci 107, 367-375.
77. Alexander JS, Hechtan HB, Shepro D 1988, Phalloidin enhances endothelial barrier function and reduces inflammatory permeability in vitro, Microvasc Res 35, 308-315.
78. Mark KS, Davis TP 2002, Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation, Am J Physiol 282, H1485-H1492.
79. Lum H, Barr DA, Shaffer JR, Gordon RJ, Ezrin AM, Malik AB 1992, Reoxygenation of endothelial cells increases permeability by oxidant-dependent mechanisms, Circ Res 70, 991-998.
80. Lagrange P, Romero I, Minn A, Revest PA 1999, Transendothelial permeability changes induced by free radicals in an in vitro model of the blood-brain barrier, Free Rad Med Biol 27, 667-672.
81. Olsson Y, Crowell RM, Klatzo I 1971, The blood-brain barrier to protein tracers in focal ischemia and infarction caused by occlusion of the middle cerebral artery, Acta Neuropathol 18, 89-102.
82. Kuroiwa T, Ting P, Martinez H, Klatzo I 1985, The biphasic opening of the blood-brain barrier to proteins following temporary middle cerebral artery occlusion, Acta Neuropathol 68, 122-129.
83. Shigeno T, Teasdale GM, McCulloch J, Graham D 1985, Recirculation model following MCA occlusion in rats: Cerebral blood flow, cerebrovascular permeability and brain edema, J Neurosurg 63, 272-277.
84. Beckman JS, Koppenol WH 1996, Nitric oxide, superoxide and peroxynitrite:the good, the bad and the ugly, Am J Physiol 271, C1424-C1437.
85. Malinski T, Bailey F, Zhang ZG, Chopp M 1993, Nitric oxide measured by a porphyrinic microsensor in rat brain after transient middle cerebral artery occlusion, J Cereb Blood Flow Metab 13, 355-358.
86. Nagafuji T, Sugiyama M, Matsui T, Muto A, Naito S 1995, Nitric oxide synthase in cerebral ischemia: possible contribution of nitric oxide synthase activation in brain microvessels to cerebral ischemic injury, Mol Chem Neuropathol 26, 107-157.
87. Dalkara T, Morikawa H, Moskowitz MA, Panahian N 1994, Blood flow-dependent functional recovery in a rat model of cerebral ischemia, Am J Physiol 267, H678-H683.
88. Huang Z, Huang PL, Panahian N, Dalkara T, Fishman MC, Moskowitz MA 1994, Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase, Science 265, 1883-1885.
89. Huang Z, Huang PL, Ma J, Meng W, Ayata C, Fishman MC, Moskowitz MA 1996, Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine, J Cereb Blood Flow Metab 16, 981-987.
90. Panahian N, Yoshida T, Huang PL, Hedley-Whyte ET, Dalkara T, Fishman M, Moskowitz MA 1996, Attenuated hippocampal damage after global cerebral ischemia in knock-out mice deficient in neuronal nitric oxide synthase, Neuroscience 72, 343-354.
91. Clemens JA, Panetta JA 1994, Neuroprotection by antioxidants in models of global and focal ischemia, in The Neurobiology of NO and OH, eds. CC Chiueh, DL Gilbert, CA Colton, New York Academy of Sciences, New York.
92. Sakomoto A, Ohnishi ST, Ohnishi T, Ogawa R 1991, Relationship between free-radical production and lipid peroxidation during ischemia-reperfusion injury in the rat brain, Brain Res 554, 186-192.
93. Oliver CN, Starke-Reed PE, Stadtman ER, Lui GJ, Carney JM, Floyd RA 1990, Oxidative damage to brain proteins, loss of glutamate synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain, Proc Natl Acad Sci USA 87, 5144-5147.
94. Kumura E, Yoshimine T, Iwatsuki KI, Yamanaka K, Tanaka S, Hayakawa T, Shiga T, Kosaka H 1996, Generation of nitric oxide and superoxide during reperfusion after focal cerebral ischemia in rats, Am J Physiol 270, C748-C752.
95. Gursoy-Ozdemir Y, Bolay H, Saribas O, Dalkara T 2000, Role of endothelial nitric oxide generation and peroxynitrite formation in reperfusion injury after focal cerebral ischemia, Stroke 31, 1974-1981.
96. Greenacre S, Ridger V, Wilsoncroft P, Brain SD 1997, Peroxynitrite: a mediator of increased microvascular permeability, Clin Exp Pharmacol Physiol 24, 880-882.
97. Gobbel GT, Chan TYY, Chan PH 1997, Nitric oxide and superoxidemediated toxicity in cerebral endothelial cells, J Pharmacol Exp Ther 282, 1600-1607.
98. Gorodeski GI 2000, NO increases permeability of cultured human cervical epithelia by cGMP-mediated increase in G-actin, Am J Physiol 278, C942-C952.
99. Beetsch JW, Park TS, Dugan LL, Shah AR, Gidday JM 1998, Xanthine oxidase-derived superoxide causes reoxygenation injury of ischemic cerebral endothelial cells, Brain Res 786, 89-95.
100. Kuhne W, Besselmann N, Noll T, Muhs A, Watanabe H, Piper HM 1993, Disintegration of cytoskeletal structure of actin filaments in energy-depleted endothelial cells, Am J Physiol 264, H1599-H1608.
101. Nagashima T, Wu S, Ikeda K, Tamaki N 2000, The role of nitric oxide in reoxygenation injury of brain microvascular endothelial cells, Acta Neurochir Suppl 76, 471-473.
102. Ding-Zhou L, Marchand-Verrecchia C, Croci N, Plotkine M, Margaill I 2002, L-NAME reduces infarction, neurologic deficit and blood-brain barrier disruption following cerebral ischemia in mice, Eur J Pharmacol 457, 137-146.
103. Jones TH, Morawetz RB, Crowell RM, Marcoux FW, Fitzgibbon SJ, DeGirolami U, Ojemann RG 1981, Thresholds of focal cerebral ischemia in awake monkeys, J Neurosurg 54, 773-782.
104. Hossman K-A 1998, Thresholds of ischemic injury, in Cerebrovascular Disease: Pathophysiology, Diagnosis and Management, eds. MD Ginsberg, J Bogousslavsky, Blackwell Science, Malden, Mass., pp. 193-204.
105. Bell BA, Symon TD, Branston NM 1985, CBF and time thresholds for the formation of ischemic cerebral edema and effect of perfusion in the baboon, J Neurosurg 62, 31-41.
106. Plateel M, Teissier E, Cecchelli R 1997, Hypoxia dramatically increases the nonspecific transport of blood-borne proteins to the brain, J Neurochem 68, 874-877.
107. Broadwell RD 1989, Transcytosis of macromolecules through the bloodbrain barrier: a cell biological perspective and critical appraisal, Acta Neuropathol 79, 117-128.
108. Coomber BL, Stewart PA 1986, Three-dimensional reconstruction of vesicles in endothelium of blood-brain barrier versus highly permeable microvessels, Anat Rec 215, 256-261.
109. Nag S, Robertson DM, Dinsdale HB 1979, Quantitative estimate of pinocytosis in experimental acute hypertension, Acta Neuropathol (Berl) 46, 107-116.
110. Kapadia SE 1984, Ultrastructural alterations in blood vessels of the white matter after experimental spinal cord trauma, J Neurosurg 61, 539-544.
111. Westergaard E, Go G, Klatzo I 1976, Increased permeability of cerebral vessels to horseradish peroxidase induced by ischemia in Mongolian gerbils, Acta Neuropathol 35, 307-325.
112. Cole DJ, Matsumura JS, Drummond JC, Schultz RL, Wong MH 1991, Time-and pressure-dependent changes in blood-brain barrier permeability after temporary middle cerebral artery occlusion in rats, Acta Neuropathol 82, 266-273.
113. Ayata C, Ropper AH 2002, Ischaemic brain edema, J Clin Neurosci 9, 113-124.
114. Spatz M, Klatzo I 1976, Ischaemic brain edema, Adv Exp Med Biol 69, 479-495.
115. 14C]sucrose and [3H]inulin across the rat blood-brain barrier after cerebral ischemia, Acta Neuropath (Berl) 103, 237-242.
116. Drewes L 2001, Molecular architecture of the brain microvasculature: perspective on blood-brain barrier transport, J Mol Neurosci 16, 93-98.
117. Hardebo JE, Owman C 1979, Barrier mechanisms for neurotransmitter monoamines and their precursors at the blood-brain barrier, Ann Neurol 8, 1-11.
118. Schilling L, Wahl M 1997, Brain edema: pathogenesis and therapy, Kidney Int 51, S69-S75.
119. Orth JD, McNiven MA 2003, Dynamin at the actin-membrane interface, Curr Opin Cell Biol 15, 31-39.
120. Abbott NJ 2000, Inflammatory mediators and modulation of blood-brain barrier permeability, Cell Mol Neurobiol 2, 131-147.
121. Kamiya T, Katayama Y, Kashiwagi F, Terashi A 1993, The role of bradykinin in mediating ischemic brain edema in rats, Stroke 24, 571-576.
122. Zausinger S 2003, Bradykinin receptor antagonists in cerebral ischemia and trauma, IDrugs 6, 970-975.
123. Raymond JJ, Robertson DM, Dinsdale HB 1986, Pharmacological modification of bradykinin induced breakdown of the blood-brain barrier, Can J Neurol Sci 13, 214-220.
124. Olesen S-P, Crone C 1986, Substances that rapidly augment ionic conductance of endothelium in cerebral venules, Acta Physiol Scand 127, 233-241.
125. Butt AM 1995, Effect of inflammatory agents on electrical resistance across the blood-brain barrier in pial microvessels of anaesthetised rats, Brain Res 696, 145-150.
126. Wahl M, Young AR, Edvinsson, Wagner F 1983, Effects of bradykinin on pial arteries and arterioles in vitro and in situ, J Cereb Blood Flow Metab 3, 231-237.
127. Gorlach C, Wahl M 1996, Bradykinin dilates rat middle cerebral artery and its large branches via endothelial B2 receptors and release of nitric oxide, Peptides 17, 1373-1378.
128. Onoue H, Kaito N, Tomii M, Tokudome S, Nakajima M, Abe T 1994, Human basilar and middle cerebral arteries exhibit endothelium-dependent responses to peptides, Am J Physiol 267, H880-H886.
129. Ding-Zhou L, Margaill I, Palmier B, Pruneau D, Plotkine M, Marchand-Verrecchia C 2003, LF 16-0687 Ms, a bradykinin B2 receptor antagonist, reduces ischemic brain injury in a murine model of transient cerebral ischemia, Br J Pharm 139, 1539-1547.
130. 2 receptor antagonist, on brain edema formation and tissue damage in a rat model of temporary focal cerebral ischemia, Brain Res 950, 268-278.
131. Subramanian N, Theodore D, Abraham J 1981, Experimental cerebral infarction in primates: regional changes in brain histamine concentration, J Neural Trans 50, 225-232.
132. Adachi N, Oishi R, Saeki K 1991, Changes in the metabolism of histamine and monoamines after occlusion of the middle cerebral artery in rats, J Neurochem 57, 61-66.
133. Dux E, Joo F 1982, Effects of histamine on brain capillaries: fine structural and immunohistochemical studies after intracarotid infusion, Exp Brain Res 47, 252-258.
134. Schilling L, Wahl M 1994, Opening of the blood-brain barrier during cortical superfusion with histamine, Brain Res 653, 289-296.
135. Toda N 1990, Mechanism underlying responses to histamine of isolated monkey and human cerebral arteries, Am J Physiol 258, H311-H317.
136. 2 receptors, Circ Res 44, 161-165.
137. Joo F, Kovacs J, Szerdahelyi P, Temesvari P, Tosaki A 1994, The role of histamine in brain oedema formation, Acta Neurochir 60, 76-78.
138. Bhakoo KK, Crockard HA, Lascelles PT 1984, Regional studies of changes in brain fatty acids following experimental ischemia and reperfusion in the gerbil, J Neurochem 43, 1025-1031.
139. Tomimoto H, Shibata M, Ihara M, Akiguchi I, Ohtani R, Budka H 2002, A comparative study on the expression of cyclooxygenase and 5-lipoxygenase during cerebral ischemia in humans, Acta Neuropathol (Berl) 104, 601-607.
140. Rao AM, Hatcher JF, Kindy MS, Dempsey RJ 1999, Arachidonic acid and leukotriene C4: role in transient cerebral ischemia in gerbils, Neurochem Res 24, 1225-1232.
141. Unterberg A, Wahl M, Hammersen F, Baethmann A 1987, Permeability and vasomotor responses of cerebral vessels during exposure to arachidonic acid, Acta Neuropathol 73, 209-219.
142. Rosenblum WI, Nelson GH 1988, Endothelium-dependent constriction demonstrated in vivo in mouse cerebral arterioles, Circ Res 63, 837-843.
143. Barbosa-Coutinho LM, Hartmann A, Hossmann K-A, Rommel T 1985, Effect of dexamethasone on serum protein extravasation in experimental brain infarcts of monkeys: An immunohistochemical study, Acta Neuropathol 65, 255-260.
144. Dux E, Ismail M, Szerdahelyi P, Joo F, Dux L, Koltai M, Draskoczy M 1990, Dexamethasone treatment attenuates the development of ischaemic brain oedema in gerbils, Neuroscience 34, 203-207.
145. Bian LG, Zhang TX, Zhao WG, Shen JK, Yang GY 1994, Increased endothelin-1 in the rabbit model of middle cerebral artery occlusion, Neurosci Lett 174, 47-50.
146. Matsuo Y, Mihara S, Ninomiya M, Fujimoto M 2001, Protective effect of endothelin type A receptor antagonist on brain edema and injury after transient middle cerebral artery occlusion in rats, Stroke 32:2143-2148.
147. Miller RD, Monsul NT, Vender JR, Lehman JC 1996, NMDS-and endothelin-1-induced increases in blood-brain barrier permeability quantitated with Lucifer Yellow, J Neurol Sci 136, 37-40.
148. Stanimirovic DB, Bertrand N, McCarron R, Uematsu S, Spatz M 1994, Arachidonic acid release and permeability changes induced by endothelins in human cerebromicrovascular endothelium, Acta Neurochir Suppl (Wien) 60, 71-75.
149. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T 1988, A novel potent vasoconstrictor peptide produced by vascular endothelial cells, Nature 332, 411-415.
150. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T 1989, The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes, Proc Natl Acad Sci USA 86, 2863-2867.
151. Lehmberg J, Putz C, Furst M, Beck J, Baethmann A, Uhl E 2003, Impact of the endothelin-A receptor antagonist BQ 610 on microcirculation in global cerebral ischemia and reperfusion, Brain Res 961, 277-286.
152. Kovacs Z, Ikezaki K, Samoto K, Inamura T, Fukui M 1996, VEGF and flt. expression time kinetics in rat brain infarct, Stroke 27, 1865-1872.
153. Hayashi T, Abe K, Suzuki H, Itoyama Y 1997, Rapid induction of vascular endothelial growth factor gene expression after transient middle cerebral artery occlusion in rats, Stroke 28, 2039-2044.
154. Lennmyr F, Ata KA, Funa K, Olsson Y, Terent A 1998, Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) following permanent and transient occlusion of the middle cerebral artery in the rat, J Neuropathol Exp Neurol 57, 874-882.
155. Fischer S, Wiesnet M, Marti HH, Renz D, Schaper W 2004, Simultaneous activation of several second messengers in hypoxia-induced hyperpermeability of brain derived endothelial cells, J Cell Physiol 198, 359-369.
156. Hofman P, Blaauwgeers HG, Tolentino MJ, Adamis AP, Nunes Cardozo BJ, Vrensen GF, Schlingemann RO 2000, VEGF-A induced hyperpermeability of blood-retinal barrier endothelium in vivo is predominantly associated with pinocytotic vesicular transport and not with formation of fenestrations, Curr Eye Res 21, 637-645.
157. Kusters B, de Waal RM, Wesseling P, Verrijp K, Maass C, Heerschap A, Barentsz JO, Sweep F, Ruiter DJ, Leenders WP 2003, Differential effects of vascular endothelial growth factor A isoforms in a mouse brain metastasis model of human melanoma, Cancer Res 63, 5408-5413.
158. Zhang ZG, Zhang L, Jiang Q, Zhabg R, Davies K, Powers C, van Bruggen N, Chopp M 2000, VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain, J Clin Invest 106, 829-838.
159. Sacco R, Zamanillo MC, Kargman D 1994, Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community: the northern Manhattan stroke study, Neurology 44, 626-634.
160. Oppenheimer S, Halfbraid BI, Oswald GA, Yudkin JS 1985, Diabetes mellitus and early mortality from stroke, Br Med J 291, 1014-1015.
161. Pulsinelli W, Levy DE, Sigsbee B 1983, Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus, Am J Med 74, 540-544.
162. Candelise L, Landi G, Orazio EN, Boccardi E 1985, Prognostic significance of hyperglycemia in acute stroke, Arch Neurol 42, 661-663.
163. Matchar DB, Divine GW, Heyman A, Feussner JR 1992, The influence of hyperglycemia on outcome of cerebral infarction, Ann Intern Med 117, 449-456.
164. Plum F 1983, What causes infarction in ischemic brain? Neurology 33, 222-233.
165. Kiers L, Davis SM, Larkins R 1992, Stroke topography and outcome in relation to hyperglycemia and diabetes, J Neurol Neurosurg Psychiatry 55, 263-270.
166. de Courten-Myers G, Myers RE, Schoolfield L 1988, Hyperglycemia enlarges infarct size in cerebrovascular occlusion in cats, Stroke 19, 623-630.
167. de Courten-Myers G, Kleinholz M, Wagner KR, Myers RE 1989, Fatal strokes in hyperglycemic cats, Stroke 20, 1707-1715.
168. Frizzell TR, Batjer HH 1997, Cerebral ischemia: insights from animal models, in Cerebrovascular Disease, ed. HH Batjer, Lippincott-Raven, Philadelphia.
169. Venables GS, Miller SA, Gibson G, Hardy JA, Strong AJ 1985, The effect of hyperglycemia on changes during reperfusion following focal cerebral ischemia in the cat, J Neurol Neurosurg Psychiatry 48, 663-669.
170. Clarke H, Marano CW, Soler AP, Mullin JM 2000, Modification of tight junction function by protein kinase C isoforms, Adv Drug Deliv Rev 41, 283-301.
171. Wolburg H, Lippoldt A 2002, Tight junctions of the blood-brain barrier:Development, composition and regulation, Vasc Pharm 38, 323-337.
172. Murray MA, Heistad DD, Mayhan WG 1991, Role of protein kinase C in bradykinin-induced increases in microvascular permeability, Circ Res 68, 1340-1348.
173. Aschner JL, Lum H, Fletcher PW, Malik AB 1993, The differential effects of protein kinase C on bradykinin-and thrombin-mediated phospholipase C activation, FASEB J 7, A719.
174. Lynch J, Ferro T, Blumenstock AM, Brockenauer AM, Malik AB 1990, Increased endothelial albumin permeability mediated by protein kinase C, J Clin Invest 85, 1991-1998.
175. Silinger-Birnboim AM, Goligorsky MS, Del Vecchio PJ, Malik AB 1992, Activation of protein kinase C pathway contributes to hydrogen peroxideinduced increase in endothelial permeability, Lab Invest 67, 24-30.
176. Yuan SY 2000, Signal transduction pathways in enhanced microvascular permeability, Microcirculation 7, 395-405.
177. Stuart RO, Nigam SK 1995, Regulated assembly of tight junctions by protein kinase C, Proc Natl Acad Sci USA 92, 6072-6076.
178. Lapierre LA 2000, The molecular structure of the tight junction, Adv Drug Deliv Rev 41, 255-264.
179. Yuan Y, Huang Q, Wu HM 1997, Myosin light chain phosphorylation: modulation of basal and agonist-stimulated venular permeability, Am J Physiol 272, H1437-H1443.
180. Lapierre LA 2000, The molecular structure of the tight junction, Adv Drug Deliv Rev 41, 255-264.
181. Lee T-S, Saltsman K, Ohashi H, King G 1989, Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications, Proc Natl Acad Sci USA 86, 5141-5144.
182. Williams B, Schrier R 1992, Characterization of glucose-induced in situ protein kinase C activity in cultured vascular smooth muscle, Diabetes 41, 1464-1472.
183. Wolf B, Williamson J, Easom R, Chang K, Sherman W, Turk J 1991, Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose levels, J Clin Invest 87, 31-38.
184. Craven P, Davidson C, DeRubertis F 1990, Increase in diacylglycerol mass in isolated glomeruli by glucose from de novo synthesis of glycerolipids, Diabetes 39, 667-674.
185. Hom S, Egleton RD, Huber JD, Davis TP 2001, Effect of reduced flow on blood-brain barrier transport systems, Brain Res 890, 38-48.
186. Iadecola C 1998, Cerebral circulatory dysregulation in ischemia, in Cerebrovascular Disease: Pathophysiology, Diagnosis and Management, Vol. 1, eds. MD Ginsberg, J Bogousslavsky, Blackwell Science, Malden, Mass., pp. 319-357.
187. Cipolla M, Lessov N, Hammer ES, Curry AB 2001, The threshold duration of ischemia for myogenic tone in middle cerebral arteries: effect on vascular smooth muscle actin, Stroke 32, 1658-1664.
188. Cipolla MJ, McCall AL, Lessov N, Porter JP 1997, Reperfusion decreases myogenic reactivity and alters middle cerebral artery function after focal cerebral ischemia in rats, Stroke 28, 176-180.
189. Kuroiwa T, Shibutani M, Okeda R 1989, Nonhyperemic blood flow restoration and brain edema in experimental focal cerebral ischemia, J Neurosurg 70, 73-80.
190. Ito U, Ohno K, Yamaguchi T, Takei, H, Tomita H, Inaba Y 1980, Effect of hypertension on blood-brain barrier; change after restoration of blood flow in post-ischemic gerbil brains; an electronmicroscopic study, Stroke 11, 606-611.